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Introduction
Malignant extragenital neoplasm with metastasis to
the uterus is uncommon. Breast cancer is the most com-
mon primary extragenital cancer metastatic to the
uterus [1]. In the United States, breast cancer accounts
for approximately one-third of all cancers in women,
and is second only to lung cancer as the leading cause
of cancer deaths in women [2]. Ductal infiltrating
carcinoma accounts for 70–75% of all breast cancers,
while lobular infiltrating carcinoma accounts for 5–
20% [3]. Although the incidence of lobular infiltrating
carcinoma is low, it is the most common histologic type
metastasizing to the female genital tract [3]. We pre-
sent a rare case of lobular infiltrating breast carcinoma
metastatic to the internal genital organs.
Case Report
A 76-year-old hypertensive woman suffered from
grade II invasive lobular infiltrating carcinoma of the
left breast with axillary lymph node (LN) metastasis,
which was diagnosed in September 2000. She under-
went modified radical mastectomy and axillary lymph
node dissection, followed by radiation therapy and
chemotherapy from October 2000 to April 2001.
Tamoxifen on a daily dosage of 20 mg was also giv-
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Objective: To present a rare case of breast cancer metastatic to the uterus, ovaries and fallopian tubes.
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en from October 2000 to April 2002. In April 2002,
she was found to have an elevated level of CA153
of 60.50 U/mL (normal range, 0–39 U/mL).
In June 2002, the level of CA153 increased to
80.90 U/mL, but cancer work-up such as chest X-ray,
mammography, chest computed tomography (CT),
abdominal ultrasound, and whole body bone scan
were all negative. At the same time, a cervical biopsy
following abnormal routine Pap smear showed a
diagnosis of cervical intraepithelial neoplasia III (CIN
III). A loop electrosurgical excision procedure and an
endocervical curettage detected focal microinvasive
squamous cell carcinoma with CIN III and a few atypical
cells in superficial stroma but without squamous or
glandular differentiation (Figure 1). The atypical cells
were positively stained by cytokeratin and negatively
stained by vimentin, actin, S-100 and mucin. Therefore,
a diagnosis of metastasis of the breast carcinoma to the
cervix was made. CT scans revealed an enlarged uter-
us with fluid density in the uterine cavity, intrauterine
calcification, and an asymmetric cervix without pelvic
lymphadenopathy (Figure 2). A total abdominal hys-
terectomy and bilateral salpingo-oophorectomy were
performed.
Grossly, the uterus was enlarged, measuring 11.5 ×
7.5 cm, with four endometrial polyps ranging from
1 to 6 cm in size (Figure 3). Both adnexae were gross-
ly normal. In addition to leiomyoma, microscopic
examination showed extensive infiltration of meta-
static tumor cells of the breast to the myometrium
(Figure 4A), endometrial polyps, cervical stroma and
soft tissue adjacent to the uterus and the cervix. The
tumor cells were consistent with metastatic lobular
carcinoma from the breast. There was no evidence of
residual CIN or squamous cell carcinoma in the cervix.
Both ovaries and the right fallopian tube were found
to have metastatic lobular carcinoma. All tumor cells
were stained positively by cytokeratin and negatively
by vimentin and desmin (Figure 4B). Most were posi-
tive for estrogen receptors and a few were positive
for progesterone receptors.
Figure 2. Computed tomography showed an enlarged uterus
with fluid density in the uterine cavity, intrauterine calcification,
and an asymmetric cervix without pelvic lymphadenopathy:
(A) without contrast medium; (B) with contrast medium.
A
B
Figure 1. Loop electrosurgical excision procedure detected:
(A) cervical intraepithelial neoplasia III and microinvasive
adenosquamous carcinoma at the cervix (× 100); (B) tumor
cells of metastatic lobular breast carcinoma in the cervix
(× 400).
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B
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Discussion
Extragenital tumors most often metastasizing to the
uterine cervix or corpus are from the breast (42.9%),
colon (17.5%), stomach (11.1%), and pancreas (11.1%)
[1]. The ovaries are the most frequent sites for meta-
static breast carcinoma in the female reproductive sys-
tem [4]. About 2–15% of breast cancer may metasta-
size to the uterus [5]. Lobular infiltrating carcinoma is
the most common type of breast carcinoma that meta-
stasizes to the uterus, especially if hormone receptors
are positive.
Breast cancer tends to metastasize via the lymphatic
system, and it may also occur via the blood stream [6].
The common distant metastatic sites are the liver,
bones and lungs. However, metastases to the female
genital tract occur most often by the contiguous spread
of neighboring tumors or by extensive peritoneal im-
plantation. In our case, the breast cancer metastasized
to all the uterine structures, including cervix, bilateral
ovaries and the right fallopian tube. Endometrial in-
volvement seems to occur by contiguous spread from
the myometrium. The tumor tends to infiltrate the
stroma while preserving the endometrial glands and
forms myometrial tumor nodules [7,8]. Weingold and
Boltuch proposed that metastases spread from the
ovaries via the lymphatic system to the uterus [9]. Most
uterine metastases from extrapelvic tumors are second-
ary to local retrograde lymphatic spread from preced-
ing ovarian metastases or possibly from hematogenous
spread when the ovaries are not affected [10].
Breast cancer metastasis to the uterus can be clinically
silent, or be suggested by abnormal uterine bleeding or
sudden increase in size of a uterine mass [11]. Uterine
leiomyoma metastasis as a first sign of breast cancer has
also been reported [12]. In our case, the presenting clini-
cal sign was virtually nonexistent. Our patient denied
any abnormal vaginal bleeding or spotting. Standard
metastatic work-up was negative except for the elevated
serum tumor marker for breast cancer. Hysterectomy
was performed for the CIN III with focal microinvasive
squamous cell carcinoma of the cervix. However, besides
Figure 3. (A) The uterus and polyps were found protruding into
the uterine cavity from the endometrium. (B) Endometrial
polyps with focal infiltration of metastatic lobular breast
carcinoma (× 40).
A
B
Figure 4. (A) Tumor cells of metastatic lobular breast carcinoma
in the myometrium (× 400). (B) Cytokeratin immunostaining
of metastatic tumor cells in the myometrium (× 400).
A
B
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looking for clinical signs and some standard metastatic
work-up, how can we detect metastatic breast cancer?
Positron emission tomography can be used to localize
breast cancer metastases suspected by the presence of
elevated serum tumor markers but not detected by
standard metastatic work-up [13]. To date, however, it
is not performed routinely during metastatic work-up.
We should keep in mind that women with breast
cancer might develop an isolated uterine metastasis
or second uterine primary tumor. The relationship be-
tween different hormone-dependent tumors and the
implications of hormone therapy make gynecologic
follow-up obligatory. Stemmermann [10] alerted
gynecologists to consider the diagnosis of metastatic
neoplasm whenever abnormal bleeding occurs in a
woman who has had a previous operation for cancer,
especially if ovarian lesions are palpable. According to
the 1996 statement from the American College of Ob-
stetricians and Gynecologists, patients with breast
carcinoma who are using tamoxifen need to have year-
ly gynecologic check-ups such as Pap smear, pelvic
examination, and vaginal and colon examinations. Any
abnormal vaginal bleeding, such as bloody discharge,
spotting, or any indication of gynecologic diseases need
to be followed up with further investigations. Endome-
trial biopsy should also be considered for any bleeding
occurrences.
In conclusion, we discovered a rare disease under
unexpected circumstances. From this experience, we
learned that even in the absence of any clinical signs
such as abnormal vaginal bleeding, women who have
hormone therapy for breast cancer should have regular,
yearly, gynecologic follow-ups.
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